Varian Medical Systems Inc.
- ExchangeNew York Stock Exchange
- SectorHealth Care Equipment & Services
- CountryUnited States
VARIAN MEDICAL SYS.INCO. (US), a company active in the Medical Equipment industry, is favoured by a more supportive environment. The independent financial analyst theScreener has confirmed the fundamental rating of the title, which shows 3 out of 4 stars, as well as its unchanged, moderately risky market behaviour. The title leverages a more favourable environment and raises its general evaluation to Slightly Positive. As of the analysis date July 3, 2020, the closing price was USD 122.39 and its potential was estimated at USD 139.99.
A director at Varian Medical Systems Inc sold 1,625 shares at 109.739USD and the significance rating of the trade was 58/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showing Close periods where trading activity is restricted under listing rules. The na...
GOOGL currently trades near corporate averages relative to UAFRS-based (Uniform) Earnings, with a 19.5x Uniform P/E. At these levels, the market is pricing in expectations for Uniform ROA to fade from 26% in 2018 to a historical low of 11% by 2023, accompanied by 22% Uniform Asset growth going forward. However, analysts have less bearish expectations, projecting Uniform ROA to only decline slightly to 21% by 2020, accompanied by 22% Uniform Asset growth. Moreover, management is confident about their product portfolio, revenue growth, and cash flow. Current valuations appear to be pricing in ov...
Varian Medical Systems, Inc. (VAR:USA) currently trades above corporate averages relative to UAFRS-based (Uniform) Earnings, with a 26.3x Uniform P/E. At these levels, the market is pricing in bullish expectations for the firm. Additionally, management is confident about their acquisitions, revenue, and growth. Specifically, management is confident they are focusing on four strategic enablers for their patients, and they are confident that the Karolinska University Hospital has begun testing their Bravos afterloader. Furthermore, they are confident Noona will reach 22,000 new cancer cases per...
Feasibility Study Results in December to be a Catalyst for this Junior
Short Shots is a collection of technically vulnerable charts culled from the Negative Inflecting and Toppy columns within our Weekly Compass report or from various technical screening processes. The charts contained in this report have developed concerning technical patterns that suggest further price deterioration is likely. For these reasons Short Shots can also be a great source of ideas for investors interested in short-selling candidates.
Key Points: • The decline in interest rates has investors seeking dividend related equities (ex. VZ, POST, VTS, WELL, ESS, O, NNN, EPR, FE, AEP, PNW, and NI) • A few Restaurants acted well despite the plunge in Friday's market (ex. DRI, MCD, YUM, and SBUX) • A few Staples Sector names are attractive. (ex. SJM, POST, SAFM, COKE, and KMB)